Although genetic testing could assist in the diagnosis of RTH, there are still up to 10%–15% of RTH patients without THRβ mutations (which we called non-TR-RTH), which may affect the diagnosis of such patients, especially for patients with pituitary tumors, leading to the wrong choice of surgical treatment (4, 26). Here, THRB is linked to thyroid hormone resistance syndrome.